These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11053474)
1. Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. DE Gracia MC; Osuna A; O'Valle F; Del Moral RG; Wangensteen R; Del Rio CG; Vargas F J Am Soc Nephrol; 2000 Nov; 11(11):1995-2000. PubMed ID: 11053474 [TBL] [Abstract][Full Text] [Related]
2. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats. Wangensteen R; O'Valle F; Del Moral R; Vargas F; Osuna A Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376 [TBL] [Abstract][Full Text] [Related]
3. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats. Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680 [TBL] [Abstract][Full Text] [Related]
4. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension. K-Laflamme A; Oster L; Cardinal R; de Champlain J Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats. Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats. Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905 [TBL] [Abstract][Full Text] [Related]
7. Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats. Kucuk M; Kaya M; Kalayci R; Cimen V; Kudat H; Arican N; Elmas I; Korkut F Life Sci; 2002 Jul; 71(8):937-46. PubMed ID: 12084390 [TBL] [Abstract][Full Text] [Related]
8. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis]. Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370 [TBL] [Abstract][Full Text] [Related]
9. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure. Alvarez G; Osuna A; Wangensteen R; Vargas F Hypertension; 2000 Mar; 35(3):752-7. PubMed ID: 10720590 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats. Vaskonen T; Mervaala E; Krogerus L; Teräväinen TL; Laakso J; Karppanen H; Vapaatalo H Hypertens Res; 1997 Sep; 20(3):183-92. PubMed ID: 9328799 [TBL] [Abstract][Full Text] [Related]
12. Effects of losartan on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats. Khattab M; Ahmad M; Al-Shabanah OA; Raza M Recept Channels; 2004; 10(5-6):147-57. PubMed ID: 15989079 [TBL] [Abstract][Full Text] [Related]
13. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat. Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709 [TBL] [Abstract][Full Text] [Related]
14. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats. Lee BH; Shin HS Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301 [TBL] [Abstract][Full Text] [Related]
15. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system. K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419 [TBL] [Abstract][Full Text] [Related]
16. Role of the central nervous system in the development of hypertension produced by chronic nitric oxide blockade in rats. Nakata T; Takeda K; Harada S; Oguni A; Hatta T; Kawa T; Itoh H; Sasaki S; Nakagawa M Hypertens Res; 2001 Jan; 24(1):39-45. PubMed ID: 11213029 [TBL] [Abstract][Full Text] [Related]
17. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats. Li JS; Sventek P; Schiffrin EL J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362 [TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of neuronal nitric oxide synthase does not affect long-term control of blood pressure in normal, saline-drinking or deoxycorticosterone-treated rats. Wangensteen R; Sainz J; Rodríguez-Gomez I; Moreno JM; Osuna A; Vargas F Exp Physiol; 2003 Mar; 88(2):243-50. PubMed ID: 12621529 [TBL] [Abstract][Full Text] [Related]
19. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats. Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005 [TBL] [Abstract][Full Text] [Related]
20. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]